GelStat Corporation Terminates Letter of Intent to Acquire Beveragette Ventures, LLC
2012年6月26日 - 1:58AM
GelStat Corporation (Other OTC:GSAC), a consumer healthcare company
primarily focused on the development and marketing of
over-the-counter (OTC) products has terminated the Letter of Intent
(LOI) to acquire Beveragette Ventures, LLC.
Make sure you are first to receive timely information on GelStat
Corporation when it hits the newswire. Sign up for GelStat's email
news alert system today at:
http://ir.stockpr.com/gelstat/request-information
ABOUT GELSTAT CORPORATION
GelStat Corporation is dedicated to providing safe and effective
over-the-counter (OTC) treatments. GelStat's first two products
GelStat Migraine and GelStat Sleep are sold through
direct-to-consumer channels as well as in a limited number of
independent retailers and pharmacies. The Company also has a suite
of additional healthcare products in various stages of development
that address large consumer markets. For more information, visit
www.gelstat.com.
CONTACT: Gerald Kieft
CEO
GelStat Corporation
772-283-0020
GelStat (PK) (USOTC:GSAC)
過去 株価チャート
から 12 2024 まで 1 2025
GelStat (PK) (USOTC:GSAC)
過去 株価チャート
から 1 2024 まで 1 2025
Real-Time news about GelStat Corporation (PK) (その他OTC): 0 recent articles
その他のGelStat Corporationニュース記事